Editorial Commentary
Dosimetric and clinical factors predicting quality of life after post prostatectomy radiation therapy: useful tool or not?
Abstract
Among all therapeutic alternatives for prostate cancer, radical prostatectomy (RP) is one of the most frequent used especially in young patients. However, after RP one third of patients will relapse either with only a rising prostate specific antigen (PSA) or a persistent elevated post-surgery PSA.